- Home
- SNGX vs BBGI Comparison
SNGX vs BBGI Comparison
Compare SNGX & BBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- BBGI
- Stock Information
- Founded
- SNGX 1987
- BBGI 1961
- Country
- SNGX United States
- BBGI United States
- Employees
- SNGX N/A
- BBGI N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- BBGI Broadcasting
- Sector
- SNGX Health Care
- BBGI Consumer Discretionary
- Exchange
- SNGX Nasdaq
- BBGI Nasdaq
- Market Cap
- SNGX 10.1M
- BBGI 8.3M
- IPO Year
- SNGX 1987
- BBGI 2000
- Fundamental
- Price
- SNGX $2.92
- BBGI $5.33
- Analyst Decision
- SNGX Strong Buy
- BBGI
- Analyst Count
- SNGX 1
- BBGI 0
- Target Price
- SNGX $6.00
- BBGI N/A
- AVG Volume (30 Days)
- SNGX 10.0M
- BBGI 3.2K
- Earning Date
- SNGX 11-07-2025
- BBGI 11-04-2025
- Dividend Yield
- SNGX N/A
- BBGI N/A
- EPS Growth
- SNGX N/A
- BBGI N/A
- EPS
- SNGX N/A
- BBGI N/A
- Revenue
- SNGX N/A
- BBGI $227,387,784.00
- Revenue This Year
- SNGX N/A
- BBGI $5.02
- Revenue Next Year
- SNGX N/A
- BBGI N/A
- P/E Ratio
- SNGX N/A
- BBGI N/A
- Revenue Growth
- SNGX N/A
- BBGI N/A
- 52 Week Low
- SNGX $1.09
- BBGI $3.67
- 52 Week High
- SNGX $6.23
- BBGI $14.95
- Technical
- Relative Strength Index (RSI)
- SNGX 51.64
- BBGI 72.21
- Support Level
- SNGX $2.58
- BBGI $4.55
- Resistance Level
- SNGX $3.11
- BBGI $4.80
- Average True Range (ATR)
- SNGX 0.22
- BBGI 0.13
- MACD
- SNGX -0.09
- BBGI 0.06
- Stochastic Oscillator
- SNGX 43.59
- BBGI 93.88
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About BBGI Beasley Broadcast Group Inc.
Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The company operates in two segments Audio and Digital.